| abstract |
The present invention discloses a bispecific antibody structure comprising a) a Fab fragment comprising a first binding site for a first antigen; b) an scFv fragment comprising a second binding site for a second antigen; c) a CH2 domain, wherein the Fab fragment and the scFv fragment are linked by a CH2 domain, wherein the first antigen is CD95 and the second antigen is CD20; or the first antigen is CD20 and the second antigen is CD95. |